Memory is preserved in older adults taking AT1 receptor blockers
Abstract Background Prior work suggests that some but not all antihypertensive treatments may benefit cognition and risk for Alzheimer’s disease, independent of stroke. Angiotensin II receptor blockers (ARBs) have been highlighted as one antihypertensive drug class that may confer greatest benefit....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2017-04-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-017-0255-9 |